WuXi Biologics Earns ISO 20400 Certification for Sustainable Procurement

WuXi Biologics has received the ISO 20400 Sustainable Procurement certification, marking a significant milestone in its commitment to sustainability in procurement practices. This certification, which is internationally recognized, underscores the company’s dedication to integrating sustainability principles throughout its procurement and supply chain management processes.

Achieving ISO 20400 certification highlights WuXi Biologics’ ongoing efforts to enhance supply chain resilience while promoting transparency and responsibility within its global value chain. The framework for the certification encompasses key aspects of supplier lifecycle management, including due diligence, risk management, supplier engagement, performance review, and termination. This comprehensive approach ensures that suppliers meet stringent quality, compliance, and sustainability criteria during their partnerships.

WuXi Biologics has emphasized that sustainability is a core component of its overall supply chain strategy. The company actively collaborates with suppliers as part of its climate and environmental initiatives. It has adopted near-term and net-zero greenhouse gas emissions reduction targets that have been approved by the Science Based Targets initiative (SBTi) and extend across its entire value chain.

Commitment to Sustainable Practices

The company’s commitment to sustainability is further exemplified through its participation in the Pharmaceutical Supply Chain Initiative (PSCI). As stated by Dr. Chris Chen, CEO of WuXi Biologics and Chairman of the ESG Committee, “As a member and active participant of PSCI, WuXi Biologics adheres to world-leading management strategies to build a robust supply chain that ultimately serves as the value chain empowering sustainable business growth.”

WuXi Biologics operates primarily as a contract development and manufacturing organization (CDMO) and offers a range of services to global pharmaceutical clients. The recent ISO 20400 certification complements its broader Environmental, Social, and Governance (ESG) programme, which has earned the company multiple sustainability ratings and recognitions from various global assessment organizations.

This achievement not only underscores WuXi Biologics’ leadership in sustainable procurement but also represents a step forward in the biotechnology industry’s efforts to promote responsible and transparent supply chain practices. The company continues to champion sustainability as a critical aspect of its operations, positioning itself as a frontrunner in the global movement towards more responsible business practices.